CoChat

Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro

Open access
Horiuchi, Makoto, Maezawa, Izumi, Itoh, Aki, Wakayama, Kouji, Jin, Lee-Way, Itoh, Takayuki, DeCarli, Charles · 2012 · Neurobiology of Aging
Cited by 84

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Accumulating evidence indicates that white matter degeneration contributes to the neural disconnections that underlie Alzheimer’s disease pathophysiology. Although this white matter degeneration is partly attributable to axonopathy associated with neuronal degeneration, amyloid β (Aβ) protein-mediated damage to oligodendrocytes could be another mechanism. To test this hypothesis, we studied effects of soluble Aβ in oligomeric form on survival and differentiation of cells of the oligodendroglial lineage using highly purified oligodendroglial cultures from rats at different developmental stages. Aβ oligomer at 10 μM or higher reduced survival of mature oligodendrocytes, whereas oligodendroglial progenitor cells (OPCs) were relatively resistant to the Aβ oligomer-mediated cytotoxicity. Further study revealed that Aβ oligomer even at 1 μM accelerated 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis in mature oligodendrocytes, and, more significantly, inhibited myelin sheet formation after induction of in vitro differentiation of OPCs. These results imply a novel pathogenetic mechanism underlying Aβ oligomer-mediated white matter degeneration, which could impair myelin maintenance and remyelination by adult OPCs, resulting in accumulating damage to myelinating axons thereby contributing to neural disconnections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2010.05.007

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 40

  1. Abe, 1998, Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes, Neurosci. Res., 31, 295, 10.1016/S0168-0102(98)00055-8 · DOI
  2. Barber, 1999, White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging, J. Neurol. Neurosurg. Psychiatry, 67, 66, 10.1136/jnnp.67.1.66 · DOI · Paper page
  3. Baumann, 2001, Biology of oligodendrocyte and myelin in the mammalian central nervous system, Physiol. Rev., 81, 871, 10.1152/physrev.2001.81.2.871 · DOI · Paper page
  4. Chen, 2006, Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes, J. Neurochem., 97, 631, 10.1111/j.1471-4159.2006.03774.x · DOI · Paper page
  5. Cho, 2008, Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study, J. Korean Med. Sci., 23, 477, 10.3346/jkms.2008.23.3.477 · DOI · Paper page
  6. de Vries, 1998, An apical-type trafficking pathway is present in cultured oligodendrocytes but the sphingolipid-enriched myelin membrane is the target of a basolateral-type pathway, Mol. Biol. Cell, 9, 599, 10.1091/mbc.9.3.599 · DOI · Paper page
  7. Debruin, 2007, White matter rafting -membrane microdomains in myelin, Neurochem. Res., 32, 213, 10.1007/s11064-006-9137-4 · DOI
  8. Diaz, 2007, Localization of MTT formazan in lipid droplets, Eur. J. Histochem., 51, 213
  9. Gielen, 2006, Rafts in oligodendrocytes: evidence and structure-function relationship, Glia, 54, 499, 10.1002/glia.20406 · DOI · Paper page
  10. Harms, 2006, Evaluation of white matter integrity in ex vivo brains of amyloid plaque-bearing APPsw transgenic mice using magnetic resonance diffusion tensor imaging, Exp. Neurol., 199, 408, 10.1016/j.expneurol.2006.01.002 · DOI
  11. Hong, 2007, Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Aβ oligomer-induced cytotoxicity, Brain Res., 1130, 223, 10.1016/j.brainres.2006.10.093 · DOI
  12. Horiuchi, 2006, MEK-ERK signaling is involved in interferon-γ-induced death of oligodendroglial progenitor cells, J. Biol. Chem., 281, 20095, 10.1074/jbc.M603179200 · DOI · Paper page
  13. Horiuchi, 2010, Differing in vitro survival dependency of mouse and rat NG2+ oligodendroglial progenitor cells, J. Neurosci. Res., 88, 957, 10.1002/jnr.22262 · DOI
  14. Itoh, 2002, AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes, J. Neurochem., 81, 390, 10.1046/j.1471-4159.2002.00866.x · DOI · Paper page
  15. Itoh, 2003, Bcl-2-related protein family gene expression during oligodendroglial differentiation, J. Neurochem., 85, 1500, 10.1046/j.1471-4159.2003.01795.x · DOI
  16. Itoh, 2000, Diminished calcium homeostasis and increased susceptibility to excitotoxicity of JS, Glia, 31, 165, 10.1002/1098-1136(200008)31:2<165::AID-GLIA80>3.0.CO;2-# · DOI
  17. Jantaratnotai, 2003, Amyloid β peptide-induced corpus callosum damage and glial activation in vivo, Neuroreport, 14, 1429, 10.1097/00001756-200308060-00005 · DOI · Paper page
  18. Kadish, 2009, Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment, J. Neurosci., 29, 1805, 10.1523/JNEUROSCI.4599-08.2009 · DOI · Paper page
  19. Klein, 2002, Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem. Int., 41, 345, 10.1016/S0197-0186(02)00050-5 · DOI · Paper page
  20. Lambert, 1998, Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. U. S. A., 95, 6448, 10.1073/pnas.95.11.6448 · DOI · Paper page
  21. Lintner, 2000, Redistribution of cholesterol in oligodendrocyte membrane sheets after activation of distinct signal transduction pathways, J. Neurosci. Res., 15, 437, 10.1002/(SICI)1097-4547(20000515)60:4<437::AID-JNR2>3.0.CO;2-9 · DOI
  22. Liu, 2004, Detecting bioactive amyloid β peptide species in Alzheimer's disease, J. Neurochem., 91, 648, 10.1111/j.1471-4159.2004.02751.x · DOI
  23. Liu, 1997, Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, J. Neurochem., 69, 581, 10.1046/j.1471-4159.1997.69020581.x · DOI · Paper page
  24. Liu, 1998, Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis, Proc. Natl. Acad. Sci. U. S. A., 95, 13266, 10.1073/pnas.95.22.13266 · DOI · Paper page
  25. Liu, 2001, A cell-based method for the detection of nanomolar concentrations of bioactive amyloid, Anal. Biochem., 289, 130, 10.1006/abio.2000.4928 · DOI
  26. Ma, 2008, p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis, J. Biol. Chem., 283, 14132, 10.1074/jbc.M708034200 · DOI · Paper page
  27. Maezawa, 2008, Congo red and thioflavin-T analogs detect Abeta oligomers, J. Neurochem., 104, 457, 10.1111/j.1471-4159.2007.04972.x · DOI · Paper page
  28. Maezawa, 2006, Congo red and thioflavin-T analogs detect Abeta oligomers, J. Neurochem., 98, 57, 10.1111/j.1471-4159.2006.03862.x · DOI · Paper page
  29. Maier, 2009, Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes, Glia, 57, 402, 10.1002/glia.20769 · DOI · Paper page
  30. Maier, 2008, Polarity development in oligodendrocytes: sorting and trafficking of myelin components, J. Mol. Neurosci., 35, 35, 10.1007/s12031-007-9024-8 · DOI
  31. Nakata, 2009, Diffusion abnormality in the posterior cingulum and hippocampal volume: correlation with disease progression in Alzheimer's disease, Magn. Reson. Imaging, 27, 347, 10.1016/j.mri.2008.07.013 · DOI
  32. Peters, 2003, Is there remyelination during aging of the primate central nervous system?, J. Comp. Neurol., 460, 238, 10.1002/cne.10639 · DOI · Paper page
  33. Polito, 2005, NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system, J. Anat., 207, 707, 10.1111/j.1469-7580.2005.00454.x · DOI · Paper page
  34. Raff, 1983, A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium, Nature, 303, 390, 10.1038/303390a0 · DOI · Paper page
  35. Song, 2001, Cytoskeletal reorganization during the formation of oligodendrocyte processes and branches, Mol. Cell. Neurosci., 17, 624, 10.1006/mcne.2001.0974 · DOI
  36. Stokin, 2005, Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease, Science, 307, 1282, 10.1126/science.1105681 · DOI · Paper page
  37. Taguchi, 2005, Biochemical and morphologic evidence of the interaction of oligodendrocyte membrane rafts with actin filaments, J. Neurosci. Res., 81, 218, 10.1002/jnr.20555 · DOI
  38. Thomas, 2002, Myosin light chain kinase inhibitors induce retraction of mature oligodendrocyte processes, Neurochem. Res., 27, 1305, 10.1023/A:1021615530960 · doi:10.1023/a:1021615530960
  39. Zeng, 2005, Amyloid-β peptide enhances tumor necrosis factor-α-induced iNOS through neural sphingomyelinase/ceramide pathway in oligodendrocytes, J. Neurochem., 94, 703, 10.1111/j.1471-4159.2005.03217.x · DOI · Paper page
  40. Zhou, 2008, Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment, Alzheimers Dement., 4, 265, 10.1016/j.jalz.2008.04.006 · DOI · Paper page

Cited by

See all 84

Metadata

Authors
Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L.-W., Itoh, T., & DeCarli, C.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2012-03
Volume
33
Issue
3
Pages
499-509
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2018767861
Cited by
84
References
15
FWCI
2.28
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • UC Davis Alzheimer's Disease Center
  • National Institute of Health Grant (P30 AG10129, R01 AG025500, R21 AG031362)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2010.05.007
The paper
Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L.-W., Itoh, T., & DeCarli, C. (2012). Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2010.05.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.